Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: Aug. 18, 2022
Abstract
Severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
gained
mutations
at
an
alarming
rate
in
the
past
years.
Developing
can
increase
virus's
pathogenicity
and
virulence;
reduce
efficacy
of
vaccines,
antibodies
neutralization,
even
challenge
adaptive
immunity.
So,
it
is
essential
to
identify
conserved
epitopes
(with
fewer
mutations)
different
variants
with
appropriate
antigenicity
target
by
vaccine
design.
Yet
as,
3369
SARS-CoV-2
genomes
were
collected
from
global
initiative
on
sharing
avian
flu
data.
Then,
immunodominant
regions
(IDRs),
immune
epitope
database
(IEDB)
epitopes,
also
predicted
calculated.
In
following,
conservity
score
against
total
number
events
(mutations)
mutated
sites
each
was
weighted
Shannon
entropy
then
calculated
Technique
for
Order
Preference
Similarity
Ideal
Solution
(TOPSIS).
Based
TOPSIS
score,
plotted.
The
result
demonstrates
that
almost
all
IDRs
various
lengths
have
numbers
dissimilar
sites.
Herein,
our
two-step
calculation
recommends
only
8
IDRs,
14
IEDB
10
among
epitopes.
selected
ones
higher
immunogenicity.
This
method
open-source
multi-criteria
decision-making
platform,
which
provides
a
scientific
approach
selecting
immunogenicity;
ever-changing
viruses.
Journal of Traditional and Complementary Medicine,
Journal Year:
2021,
Volume and Issue:
12(1), P. 35 - 43
Published: June 3, 2021
A
novel
coronavirus,
called
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
been
found
to
cause
COVID-19
in
humans
and
some
other
mammals.
The
nonstructural
protein
16
(NSP16)
of
SARS-CoV-2
plays
a
significant
part
replication
viruses
suppresses
ability
innate
immune
system
detect
virus.
Therefore,
inhibiting
NSP16
can
be
secure
path
towards
identifying
potent
medication
against
SARS-CoV-2.
Tea
(
Chemical Reviews,
Journal Year:
2022,
Volume and Issue:
122(13), P. 11287 - 11368
Published: May 20, 2022
Despite
tremendous
efforts
in
the
past
two
years,
our
understanding
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
virus-host
interactions,
immune
response,
virulence,
transmission,
and
evolution
is
still
very
limited.
This
limitation
calls
for
further
in-depth
investigation.
Computational
studies
have
become
an
indispensable
component
combating
disease
2019
(COVID-19)
due
to
their
low
cost,
efficiency,
fact
that
they
are
free
from
safety
ethical
constraints.
Additionally,
mechanism
governs
global
transmission
SARS-CoV-2
cannot
be
revealed
individual
experiments
was
discovered
by
integrating
genotyping
massive
viral
sequences,
biophysical
modeling
protein-protein
deep
mutational
data,
learning,
advanced
mathematics.
There
exists
a
tsunami
literature
on
molecular
modeling,
simulations,
predictions
related
developments
drugs,
vaccines,
antibodies,
diagnostics.
To
provide
readers
with
quick
update
about
this
literature,
we
present
comprehensive
systematic
methodology-centered
review.
Aspects
such
as
biophysics,
bioinformatics,
cheminformatics,
machine
mathematics
discussed.
review
will
beneficial
researchers
who
looking
ways
contribute
those
interested
status
field.
Frontiers in Medicine,
Journal Year:
2022,
Volume and Issue:
9
Published: May 19, 2022
Background
Currently,
promoted
vaccinations
against
SARS-CoV-2
are
being
given
out
globally.
However,
the
occurrence
of
numerous
COVID-19
variants
has
hindered
goal
rapid
mitigation
pandemic
by
effective
mass
vaccinations.
The
real-word
effectiveness
current
vaccines
not
been
assessed
published
reviews.
Therefore,
our
study
evaluated
overall
and
differences
between
various
variants.
Methods
PubMed,
Embase,
Cochrane
Library,
medRxiv,
bioRxiv,
arXiv
were
searched
to
screen
eligible
studies.
Newcastle–Ottawa
scale
Egger
test
applied
estimate
quality
literature
any
publication
bias,
respectively.
pooled
incident
rates
different
after
vaccination
estimated
single-arm
analysis.
Meanwhile,
efficacies
two-arm
analysis
using
odds
ratios
(ORs)
vaccine
(VE).
Results
A
total
6,118
studies
identified
initially
44
articles
included.
We
found
that
incidence
post
first/second
0.07
0.03,
VE
first
placebo
or
unvaccinated
population
was
40%
second
96%,
sub-single-arm
showed
a
low
prevalence
rate
specific
with
below
0.10
in
most
subgroups.
sub-two-arm
indicated
had
good
moderate
preventive
effect
on
certain
considering
these
subgroups
66
95%,
which
broadly
line
results
Conclusion
Our
meta-analysis
shows
used
globally
could
prevent
infection
restrict
spread
great
extent.
would
also
support
maximizing
uptake
two
doses,
as
more
marked
compared
one
dose.
Although
mRNA
according
study,
should
be
taken
into
account
based
local
dominant
Phytomedicine,
Journal Year:
2022,
Volume and Issue:
98, P. 153970 - 153970
Published: Jan. 30, 2022
The
COVID-19
pandemic
will
continue
to
threaten
our
health
care
systems
in
the
next
years.
In
addition
vaccination
there
is
a
need
for
effective
tools
prevention
and
treatment.
Products
from
natural
sources,
like
standardized
plant
extracts
offer
wide
range
of
antiviral
effects
possible
applications.